The Citizens Commission on Human Rights (CCHR) International has released an analysis of more than 50 psychiatric hospitals across 23 states that administer electroconvulsive therapy (ECT), finding that none have updated their websites to reflect the adverse effects the U.S. Food and Drug Administration (FDA) required for mitigating risks in 2018. According to CCHR, tens of thousands of Americans, including children, are not being warned about long-term memory loss and potential brain damage, warranting a government investigation and review of the need to ban ECT devices.
The FDA’s 2018 final rule reclassified ECT devices from high-risk Class III to lower-risk Class II for limited uses, a change that thousands opposed, with many calling for an outright ban. The rule justified the reclassification partly by requiring patient labeling to warn that ‘[t]he long-term safety and effectiveness of ECT treatment has not been demonstrated’ and recommending formal neuropsychological assessments before and during treatment to monitor cognitive damage. However, CCHR’s review of hospital websites found that none of the facilities report this information.
The review also showed that hospitals failed to warn of permanent memory loss (88% of facilities), cardiovascular problems (69%), and the right to refuse consent (88%). Federal agencies bear much of ECT’s costs, even though psychiatrists admit it cannot cure and often requires ongoing ‘maintenance’ treatments. A private insurance analysis found that ECT patients are hospitalized 4 to 29 days longer than those receiving standard treatment, with additional healthcare costs of $5,700 to $52,700.
ECT delivers up to 460 volts of electricity through the brain to induce a grand mal seizure, involving loss of consciousness and violent muscle contractions masked by anesthetics and muscle relaxants. Higher voltages used today have increased risks. Devices were grandfathered in 1976 without premarket approval or clinical trials proving safety and efficacy. The FDA’s 2018 Final Rule specified there is no clinical data supporting safety and efficacy for schizophrenia, schizoaffective disorder, or mania (which remain Class III). Despite this, 71% of the hospitals promote ECT for schizophrenia/schizoaffective disorders—including the Department of Veterans Affairs—and 35% promote it for mania. The FDA lists mania and worsening psychiatric symptoms as adverse effects. Some hospitals also promote it off-label for autism, Alzheimer’s, Parkinson’s, and dementia, despite ECT’s known memory loss effects.
Many hospital claims are misleading and unsubstantiated, including comparing ECT to jump-starting a car battery (a jump start typically uses 12 to 14 volts, while ECT uses more than 30 times that) or stating that ECT ‘turns the brain on and off just like a computer.’ The need for full informed consent regarding ECT has been upheld in courts, especially with a warning about potential brain damage. Expert testimony before the Nebraska Supreme Court in 2025 concluded that ‘ECT causes persistent or permanent memory loss and brain damage in a substantial proportion of recipients—somewhere between 12% and 55%,’ a finding which the court upheld. Neuropathologists equate ECT’s effects to traumatic brain injury, with victims suffering permanent cognitive impairment, according to Wisner Baum.
The FDA erroneously believed that involuntary ECT is ‘uncommon’ and always requires a judicial proceeding. In reality, state laws vary widely: six states have no ECT laws; many jurisdictions lack provisions for judicial oversight. Only seven states require a court order for ECT on minors; 12 have no regulations for children. Texas and California ban ECT on minors, due to CCHR’s actions.
Jan Eastgate, President of CCHR International, who received ECT in 1975 after a misdiagnosis, stated: ‘After antidepressants worsened my condition, I was told I needed ECT, that it was the same as jump-starting the heart, and there were no major side effects. It was a lie. The claims comparing it to dental work, childbirth, or defibrillating the heart are fraudulent, and the practice should be banned.’ CCHR calls for individuals damaged by ECT to report the abuse and encourages families and doctors to watch its documentary, Electroshock: Therapy or Torture.
This news story relied on content distributed by 24-7 Press Release. Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is Psychiatric Hospitals Omit FDA-Mandated ECT Warnings, CCHR Analysis Finds.